Abstract
Glutamine is the most important donor of NH3 in kidney playing an important role in acid–base buffering system. Besides this effect, glutamine presents many other relevant functions in the whole body, such as a precursor of arginine in adult and neonates. In addition to these effects, some studies have shown that glutamine can potentiate renal disease. In the present study, the effect of short-term treatment (15 days) with glutamine on control and diabetic rats was investigated. Using biochemical, histological and molecular biology analysis from control and diabetic rats we verified that glutamine supplementation increase in pro-inflammatory interleukins (IL)-1β and IL-6 content in renal cortex and induce alteration in glomerular characteristics. This study showed that short-term treatment with glutamine in association with increased glucose levels could cause important alterations in glomerular morphology that may result in fast progression of kidney failure.
Similar content being viewed by others
References
Abbott F, Ryan J, Ceska M et al (1990) Interleukin-1beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int 40:597–605
Amann K, Rump LC, Simonaviciene A et al (2000) Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol 11(8):1469–1478
Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993–2000
Barham D, Trinder P (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97(151):142–145
Bernt E, Bergmeyer HU (1974) l-Glutamate UV-assay with glutamate dehydrogenase and NAD+. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic, London, pp 1704–1704
Biederman J, Yee J, Cortes P (2004) Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis. Kidney Int 66:2308–2314
Biggs HG, Cooper JM (1961) Modified Folin methods for the measurement of urinary creatine and creatinine. Clin Chem 7:655–664
Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652–659
Carstens SA, Hebert LA, Garancis WF et al (1982) Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis Recognition and treatment. JAMA 247(10):1453–1457
Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15(3):532–534
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162:156–159
Coleman DL, Ruef C (1992) Interleukin-6: an autocrine regulator of mesangial cell growth. Kidney Int 41:604–606
Curi R, Lagranha CJ, Doi SQ et al (2005) Glutamine-dependent changes in gene expression and protein expression. Cell Biochem Funct 23(2):77–84
Curthoys NP, Gstraunthaler G (2000) Mechanism of increased renal gene expression during metabolic acidosis. Am J Physiol 281:F381–F390
Curthoys NP, Watford M (1995) Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15:133–159
Davies M, Coles GA, Thomas GJ et al (1990) Proteinases and the glomerulus: their role in glomerular diseases. Klin Wochenschr 68(22):1145–1149
Deferrari G, Garibotto G, Robaudo C et al (1985a) Leg metabolism of amino acids and ammonia in patients with chronic renal failure. Clin Sci (Colch) 69:143–151
Deferrari G, Garibotto G, Robaudo C et al (1985b) Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency. Am J Clin Nutr 48:72–83
Diamond JR, Karnovsky MJ (1998) Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32:671–678
Eid A, Bodim S, Ferrier B, Delage H et al (2006) Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. J Am Soc Nephrol 17(2):398–405
El Nahas AM, Bassett AH, Cope GF, Le Carpentier JE (1991) Role of growth hormone in the development of experimental renal scarring. Kidney Int 40:29–34
Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28(10):2077–2080
Fukatsu A, Matsuo S, Yuzawa Y et al (1993) Expression of interleukin-6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Lab Invest 69:58–67
Grond J, Weening JJ, Elema JD (1984) Glomerular sclerosis in nephritic rats: comparison of the long-term effects of adriamycin and aminonucleoside. Lab Invest 51:277–285
Grond J, Koudstaal J, Elema JD (1985) Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis. Kidney Int 27:405–410
Gross ML, Ritz E, Schoof A et al (2004) Comparison of renal morphology in the streptozotocin and SHR/N-cp models of diabetes. Lab Invest 84:452–464
Gstraunthaler G, Holcomb T, Feifel E et al (2000) Differential expression and acid–base regulation of glutaminase mRNAs in gluconeogenic LLC-PK(1)-FBPase(+) cells. Am J Physiol 278:F227–F237
Higuchi R, Dollinger G, Walsh PS et al (1992) Simultaneous amplification and detection of specific DNA sequences. Biotechnology (New York) 10:413–417
Horii Y, Muraguchi A, Iwano M et al (1989) Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949–3955
Horii Y, Iwano M, Hirata E et al (1993) Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 43(Suppl 39):S71–S75
Hostetter TH, Olson JL, Rennke HG et al (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 241:F85–F93
Kasiske BL, O’Donnell MP, Cleary MP et al (1988) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667–672
Kolm-Litty V, Sauer U, Nerlich A et al (1998) High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101(1):160–169
Lagranha CJ, Doi SQ, Pithon-Curi TC et al (2008) Glutamine enhances glucose induced mesangial cell proliferation. Amino Acids 34(4):683–685
Ling H, Ardjomand P, Samvakas S, Simm A et al (1998) Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH. Kidney Int 53(6):1706–1712
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402–408
Lui SL, Chan KW, Yip PS et al (2002) Simultaneous occurrence of diabetic glomerulosclerosis, IgA nephropathy, crescentic glomerulonephritis, and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity in a Chinese patient. Am J Kidney Dis 40(4):E14
Malide D, Russo P, Bendayan M (1995) Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 26:558–564
Martinez E, Doolan PD (1960) Determination of creatinine in small quantities of plasma. Observations on two methods. Clin Chem 6:233–242
Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358–1373
Masson E, Wiernsperger N, Lagarde M et al (2005) Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 388(Pt 2):537–544
Masson E, Lagarde M, Wiernsperger N et al (2006) Hyperglycemia and glucosamine-induced mesangial cell cycle arrest and hypertrophy: common or independent mechanisms? IUBMB Life 58(7):381–388
Matthews DE, Campbell RG (1992) The effect of dietary protein intake on glutamine and glutamate nitrogen metabolism in humans. Am J Clin Nutr 55(5):963–970
Mazzucco G, Dogliani M, Castello R et al (1985) Essential mixed cryoglobulinemic glomerulonephritis associated with diabetic glomerulosclerosis. Light, immunofluorescence, and ultrastructural study of two cases. Arch Pathol Lab Med 109(11):1036–1039
Meek RL, Cooney SK, Flynn SD et al (2003) Amino acids induce indicators of response to injury in glomerular mesangial cells. Am J Physiol Renal Physiol 285(1):F79–F86
Monga G, Mazzucco G, di Belgiojoso GB et al (1989) Pattern of double glomerulopathies: a clinicopathologic study of superimposed glomerulonephritis on diabetic glomerulosclerosis. Mod Pathol 2(4):407–414
Murphy M, Godson C, Cannon S et al (1999) Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274(9):5830–5834
Osterby R, Tapia J, Nyberg G et al (2001) Renal structures in type 2 diabetic patients with elevated albumin excretion rate. APMIS 109:751–761
Osterby R, Hartmann A, Nyengaard JR et al (2002) Development of renal structural lesions in type 1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies. Virchows Arch 440:94–101
Pearson S, Stern S, McGavack TH (1952) A rapid procedure for the determination of serum cholesterol. J Clin Endocrinol Metab 12(9):1245–1246
Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e 45
Pithon-Curi TC, Sellitti DF, Curi R et al (2006) Requirement for glutamine in the expression of alpha-actin and type IV collagen in mesangial cells. Cell Biochem Funct 24(3):217–221
Remuzzi G, Bertani T (1990) Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384–394
Ruef C, Budde K, Lacy J, Northermann W et al (1990) Interleukin-6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249–257
Sassy-Prigent C, Heudes D, Mandet C et al (2000) Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49:466–475
Schwarz U, Amann K, Orth SR et al (1998) Effect of 1, 25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 53(6):1696–1705
Sedor J, Nakazato Y, Konieczkowski M (1992) Interleukin-1 and the mesangial cell. Kidney Int 41:595–599
Sedor JR, Konieczkowski M, Huang S et al (1993) Cytokines, mesangial cell activation and glomerular injury. Kidney Int 39(Suppl):S65–S70
Shewchuk LD, Baracos VE, Field CJ (1997) Dietary l-glutamine supplementation reduces the growth of the Morris Hepatoma 7777 in exercise-trained and sedentary rats. J Nutr 127(1):158–166
Singh LP, Crook ED (2000) Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C. Am J Physiol Renal Physiol 279(4):F646–F654
Singh LP, Andy J, Anyamale V et al (2001) Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C. Diabetes 50(10):2355–2362
Singh LP, Alexander M, Greene K et al (2003) Overexpression of the complementary DNA for human glutamine: fructose-6-phosphate amidotransferase in mesangial cells enhances glucose-induced fibronectin synthesis and transcription factor cyclic adenosine monophosphate-responsive element binding phosphorylation. J Investig Med 51(1):32–41
Singh LP, Cheng DW, Kowluru R et al (2007) Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti-oxidant alpha-lipoic acid. Cell Biochem Funct 25(5):537–550
Steffes MW, Osterby R, Chavers B et al (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077–1081
Stumvoll M, Perriello G, Meyer C et al (1999) Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int 5:778–779
U.S. Renal Data System (2005) USRDS 2005 annual data report: atlas of end-stage renal disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda
Wahab NA, Yevdokimova N, Weston BS et al (2001) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359(Pt 1):77–87
Waldherr R, Noronha IL, Niemir Z et al (1993) Expression of cytokines and growth factors in human glomerulonephritis. Pediatr Nephrol 7:471–478
Weening JJ, Beukers JJB, Grond J et al (1986) Genetic factors in focal segmental glomerulosclerosis. Kidney Int 29:789–798
Weigert C, Friess U, Brodbeck K et al (2003) Glutamine: fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta 1 and fibronectin expression in mesangial cells. Diabetologia 46:852–855
Williamson DH, Brosnan JT (1974) Concentrations of metabolites in animal tissues. In: Bergmeyer HU (ed) Methods in enzymatic analysis. Academic, New York
Windmueller HG, Spaeth AE (1974) Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 249:5070–5079
Yoshida Y, Fogo A, Ichikawa I (1989) Glomerular hemodynamic changes versus hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654–660
Yoshioka K, Takemura T, Murakami K et al (1993) In situ expression of cytokines in IgA nephritis. Kidney Int 44:825–833
Zatz R, Meyer TW, Rennke HG et al (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82:5963–5967
Zoja C, Benigni A, Piccinini G et al (1993) Interleukin-6 stimulates gene expression of extracellular matrix components in bovine mesangial cells in culture. Mediators Inflamm 2:429–433
Acknowledgments
The authors are indebted to the constant assistance of Rui Curi and Sonia Q. Doi. The authors are grateful to Cleusa M.R. Pellegrini, Érica P. Portiolli, Fernanda A.C. Barreuce, Geraldina de Souza, José R. Mendonça and Renata Giacon for technical assistance. This research was supported by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Pesquisa (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Conflict of interest
The authors declare that there is no conflict of interest that would prejudice the impartiality of this scientific work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alba-Loureiro, T.C., Ribeiro, R.F., Zorn, T.M.T. et al. Effects of glutamine supplementation on kidney of diabetic rat. Amino Acids 38, 1021–1030 (2010). https://doi.org/10.1007/s00726-009-0310-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-009-0310-3